VivoSeq
Other

Muscle Relaxants

2

Pipeline Programs

1

Active Trials

0

Companies Involved

Muscle Relaxants is an early-stage landscape with 2 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

6

clinical trials

Completed4 · 67%
Recruiting1 · 17%
Unknown status1 · 17%

Trial Activity

6 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)